Go to main content

​​

​​​​​​​​​​​​​


Porse Group

Our research group addresses the molecular mechanisms governing both normal and malignant hematopoiesis with the aim to identify novel targets for future therapeutic intervention in patients suffering from AML.

Research Vision

Several cancers, including acute myeloid leukemias (AML), are maintained by cancer stem cells (CSCs). Similar to normal stem cells, CSCs are able to self-renew and are thus the cells that need to be targeted in order to efficiently eradicate the disease.

The focus of the Porse group is therefore to study cancer from a stem-cell centric viewpoint. Specifically, we address the molecular mechanisms governing both normal and malignant hematopoiesis with the aim to identify novel targets for future therapeutic intervention in patients suffering from AML.

​Research Focus

To address our overall research vision, the overarching goals are to:

  • Understand the gene regulatory mechanisms that governs the behavior of normal HSCs and myeloid lineage decision events during normal hematopoiesis
  • Understand the gene regulatory mechanisms governing the behavior of leukemic stem and progenitor cells
  • To use the knowledge gained from 1) and 2) to identify novel potential targets for future treatment of leukemia. By working at the interface between normal and malignant hematopoiesis we will able to gain novel insights into both processes with the ambition to translate our findings for the benefit of future leukemia patients.​

Orcid profile of Bo Porse

​​Orcid profile of Bo Porse including CV and publications



Last updated:
Responsible editor
Klik for at scrolle op eller ned p� siden G� til toppen af siden